UNSPSC 51452102: Nitroxinil or nitroxynil

This classification denotes an antihelminthic agent with the molecular formula C7H3IN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9L0EXQ7125, chemically known as benzonitrile, 4-hydroxy-3-iodo-5-nitro- but generally known as nitroxinil, which bears US NIH Compound Identifier 15532. European Medicines Agency schedules Nitroxinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09330MIG. The term NITROXINIL is an International Non-Proprietary Name.

NITROXINIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Nitroxinil or nitroxynil bears US NLM identifiers UMLS ID C0028217 and NCI Concept Code C75227. SMILES: C1=C(C=C(C(=C1[N+](=O)[O-])O)I)C#N.

UNSPSC 51452102 Nitroxinil or nitroxynil (Commodity) encompasses pharmaceutical and medical-supply procurement by state and local health agencies, emergency-response departments, and cooperative purchasing alliances, though the recent opportunities tagged under this code show significant divergence from the nominal scope—the actual solicitations involve naloxone, generic pharmaceuticals, OTC products, and emergency medical supplies rather than the specific active ingredient the code name identifies. State and local issuers under this code include county health departments, city fire and rescue divisions, state health and human services commissions, and multi-state cooperative purchasing organizations. The work being solicited ranges from direct purchase of emergency medical consumables—including naloxone units, endotracheal tubes, cardiac monitoring electrodes, bandaging materials, and oxygen delivery systems—to establishment of master supply agreements with pharmaceutical manufacturers for generic drugs and OTC products distributed through authorized wholesalers to multiple government facilities.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (due July 26, 2023) seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford; the City of Tampa issued sealed-bid solicitation 26P00145 in March 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies totaling an estimated contract value of $700,000 for the Tampa Fire Department Rescue Division, with the procurement designated as a sheltered-market opportunity for certified Small Local Business Enterprises offering a 5 percent bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs, and the Minnesota Department of Administration's Office of State Procurement administered MMCAP's RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, requiring vendors to distribute through AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson.